| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |